Physician profile
Michael L Markel
NPI 1386643096
$5,497.45
in general payments reported to CMS, 2019-2025
20 companies · $265 in 2025
The $265 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $396 · 2020: $562 · 2021: $164 · 2022: $1,047 · 2023: $729 · 2024: $2,335 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,234 · Travel and Lodging: $1,095.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,234.02 |
| Travel and Lodging | $1,094.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,842.67 | 2024 | Micra, Na |
| Abbott Laboratories | $998.91 | 2020-2025 | Confirm Rx |
| Janssen Pharmaceuticals, INC | $540.59 | 2020-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $365.73 | 2021-2024 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $338.59 | 2020-2025 | Lifevest |
| Boston Scientific Corporation | $238.13 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $215.41 | 2023-2025 | Camzyos |
| Biotronik INC. | $192.32 | 2019-2021 | |
| Kestra Medical Technology Services, INC. | $190.24 | 2022-2024 | Assure Wcd |
| Esperion Therapeutics, INC. | $98.89 | 2020 | |
| Amgen INC. | $87.36 | 2022-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $62.48 | 2023-2024 | |
| Medtronic Vascular, INC. | $57.76 | 2019 | |
| Merck Sharp & Dohme LLC | $54.43 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $51.33 | 2019-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $39.94 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $33.22 | 2019-2024 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $32.49 | 2025 | |
| Elutia, INC. | $32.29 | 2023-2024 | Ecm Patch,Pouch |
| Philips North America LLC | $24.67 | 2024 | (Cm9) Amb Mon & Diag Und |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Markel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.